Seizert Capital Partners LLC Purchases 45,515 Shares of Cigna Group $CI

Seizert Capital Partners LLC lifted its holdings in shares of Cigna Group (NYSE:CI) by 30.2% in the third quarter, Holdings Channel.com reports. The fund owned 196,006 shares of the health services provider’s stock after purchasing an additional 45,515 shares during the quarter. Cigna Group accounts for approximately 2.4% of Seizert Capital Partners LLC’s portfolio, making the stock its 12th largest position. Seizert Capital Partners LLC’s holdings in Cigna Group were worth $56,499,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Pathway Financial Advisers LLC boosted its stake in Cigna Group by 2.3% in the 2nd quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock valued at $496,000 after buying an additional 34 shares in the last quarter. Armstrong Advisory Group Inc. lifted its holdings in shares of Cigna Group by 17.7% during the third quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock valued at $65,000 after acquiring an additional 34 shares during the period. HM Payson & Co. boosted its stake in shares of Cigna Group by 0.9% in the 3rd quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock valued at $1,091,000 after purchasing an additional 35 shares in the last quarter. Carr Financial Group Corp grew its holdings in shares of Cigna Group by 5.3% in the 3rd quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock worth $204,000 after purchasing an additional 36 shares during the last quarter. Finally, Natural Investments LLC increased its position in shares of Cigna Group by 2.0% during the 3rd quarter. Natural Investments LLC now owns 1,843 shares of the health services provider’s stock worth $531,000 after purchasing an additional 36 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on CI shares. Robert W. Baird reduced their price target on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research report on Thursday, December 11th. Guggenheim reiterated a “buy” rating and set a $318.00 price target on shares of Cigna Group in a research report on Tuesday, December 2nd. Morgan Stanley restated an “overweight” rating and set a $355.00 price objective on shares of Cigna Group in a report on Friday, October 31st. Wells Fargo & Company reduced their price target on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a research report on Wednesday, November 5th. Finally, The Goldman Sachs Group dropped their price objective on Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a research note on Tuesday, November 4th. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and an average target price of $330.48.

Insider Activity

In other Cigna Group news, CEO David Cordani acquired 4,134 shares of the company’s stock in a transaction on Monday, November 3rd. The shares were purchased at an average cost of $241.88 per share, with a total value of $999,931.92. Following the completion of the purchase, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.70% of the stock is currently owned by corporate insiders.

Cigna Group Stock Performance

Shares of CI stock opened at $273.08 on Tuesday. The firm has a 50 day moving average of $273.93 and a 200-day moving average of $286.51. The company has a market cap of $72.95 billion, a price-to-earnings ratio of 12.02, a price-to-earnings-growth ratio of 0.96 and a beta of 0.26. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.74. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The business had revenue of $69.57 billion during the quarter, compared to analysts’ expectations of $66.40 billion. During the same period last year, the company posted $7.51 earnings per share. The business’s quarterly revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th were issued a dividend of $1.51 per share. The ex-dividend date was Thursday, December 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.2%. Cigna Group’s payout ratio is currently 26.64%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.